Cabot (NYSE:CBT) CEO Sean Keohane Sells 2,779 Shares

Cabot Corporation (NYSE:CBT) CEO Sean Keohane sold 2,779 shares of the stock in a transaction on Monday, August 24th. The shares were sold at an average price of $85.50, for a total transaction of $237,604.50. Following the completion of the sale, the chief executive officer directly owned 288,873 shares in the company, valued at approximately $24,698,641.50. This represents a 0.95% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Cabot Price Performance

CBT stock opened at $84.68 on Thursday. The stock has a market cap of $4.37 billion, a PE ratio of 23.85, a P/E/G ratio of 10.98 and a beta of 0.84. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53. The company has a 50-day moving average price of $87.91 and a 200 day moving average price of $81.11. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48.

Cabot (NYSE:CBT) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. The business had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities research analysts anticipate that Cabot Corporation will post 6.35 earnings per share for the current year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a $0.4725 dividend. This represents a $1.89 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s payout ratio is 53.24%.

Institutional Trading of Cabot

A number of hedge funds have recently bought and sold shares of CBT. NewEdge Advisors LLC increased its position in shares of Cabot by 2,559.5% during the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after purchasing an additional 947 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Cabot by 32.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after buying an additional 108,645 shares during the period. Empowered Funds LLC increased its stake in Cabot by 102.6% during the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after buying an additional 14,260 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Cabot by 3.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after buying an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its position in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. Truist Financial set a $100.00 price objective on shares of Cabot in a report on Wednesday, August 5th. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. UBS Group cut their target price on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. Finally, Mizuho upped their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $89.00.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.